Portal Vein Thrombosis in Patients with Liver Cirrhosis: What Went Wrong?

References

• Acuna-Villaorduna A, Tran V, Gonzalez –lugo JD, Azimi-Nekoo E, Billett HH. Natural history and clinical outcomes in patients with portal vein thrombosis by etiology: a retrospective cohort study. Thromb Res. 2019;174:137–140. doi:10.1016/j.thromres.2018.12.019
   PubMed Web of Science ®Google Scholar
• Ogren M, Bergovits D, Byorck M, et al. Portal vein thrombosis, patients characteristics and life time risk: a population study based on 23796 consecutive autopsies. World J Gastroenterol. 2006;1(2):2115–2119. doi:10.3748/wjg.v12.i13.2115
   Google Scholar
• Wolberg AS, Alerman M, Leiderman K, Machlus KL. Procoagulant activity in hemostasis and thrombosis: virchow’s triad revisited. Anesth Analg. 2012;114(2):275–285. doi:10.1213/ANE.0b013e31823a088c
   PubMed Web of Science ®Google Scholar
• Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol. 2000;32:865–871. doi:10.1016/S0168-8278(00)80259-7
   PubMed Web of Science ®Google Scholar
• Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999;353(9159):1167–1173. doi:10.1016/S0140-6736(98)10266-0
   PubMed Web of Science ®Google Scholar
• Amitrano L, Guardascione MA, Brancaccio V, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 2004;40(5):736–741. doi:10.1016/j.jhep.2004.01.001
   PubMed Web of Science ®Google Scholar
• Plessier A, Darwish Murad S, Hernandez Guerra M, et al. European network for vascular disorders of the liver (En-Vie). Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology. 2010;51:1210–1218. doi:10.1002/hep.23259
   Web of Science ®Google Scholar
• Chawla YK, Bodh V. Portal vein thrombosis. J Clin Exp Hepatol. 2015;5:22–40. doi:10.1016/j.jceh.2014.12.008
   PubMedGoogle Scholar
• Cirera I, Bauer TM, Navasa M, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol. 2001;34(1):32–37. doi:10.1016/S0168-8278(00)00013-1
   PubMed Web of Science ®Google Scholar
• Georgescu D, Iurciuc MS, Ionita I, et al. Portal vein thrombosis and gut dysbiosis: understanding the burden. Rev Chim. 2019;70(6):2181–2185. doi:10.37358/RC.19.6.7301
   Web of Science ®Google Scholar
• Lee EYP, Khong PL. The value of 18 FDG PET scan in detection of tumor thrombus Clin. Nucl Med. 2013;38:e60–5.
   Google Scholar
• Lee HK, Park SJ, Yi BH, et al. Portal vein thrombosis: CT features. Abdom Imaging. 2008;33(1):72–79. doi:10.1007/s00261-007-9200-x
   PubMedGoogle Scholar
• Webster GJ, Burroughs AK, Riordan SM. Portal vein thrombosis: new insight into etiology and management. Aliment Pharmacol Ther. 2005;21:1–9. doi:10.1111/j.1365-2036.2004.02301.x
   PubMed Web of Science ®Google Scholar
• Garcia-Pagan JC, Valla DC. Portal vein thrombosis: a predictable milestone in cirrhosis? J Hepatol. 2009;51(4):632–634.
   PubMed Web of Science ®Google Scholar
• European Association For The Study Of The Liver. EASL Clinical practice Guidelines: vascular diseases of the liver. J Hepatol. 2015;63(1):179–202.
   Google Scholar
• Senzolo M, Tibbals J, Cholongitas E, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther. 2006;23(6):767–775. doi:10.1111/j.1365-2036.2006.02820.x
   PubMed Web of Science ®Google Scholar
• Ma J, Yan Z, Luo J, Liu Q, Wang J, Qiu S. Rational classification of portal vein thrombosis and its clinical significance. PLoS One. 2014;9(11):e112501. doi:10.1371/journal.pone.0112501
   PubMed Web of Science ®Google Scholar
• Ponziani FR, Zocco MA, Campanele C, et al. Portal vein thrombosis: insight into physiopathology and treatment. World J Gastroenterol. 2010;16(2):143–155.
   PubMed Web of Science ®Google Scholar
• De Franchis R. Expanding consensus in portal hypertension report of the baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743–752. doi:10.1016/j.jhep.2015.05.022
   PubMed Web of Science ®Google Scholar
• Bhangui P, Lim C, Levesque E, et al. Novel classification of no-malignant portal vein thrombosis: a guide to surgical decision-making during liver transplantation. J Hepatol. 2019;71(5):1038–1050. doi:10.1016/j.jhep.2019.08.012
   PubMed Web of Science ®Google Scholar
• Wu M, Schuster M, Tadros M. Update on management of portal vein thrombosis and the role of novel anticoagulants. J Clin Transl Hepatol. 2019;7(2):154–164. doi:10.14218/JCTH.2018.00057
   PubMed Web of Science ®Google Scholar
• Kreutziger LB, Ageno W, Lee A. Management of incidental splanchnic vein thrombosis in cancer patients. Hematololgy. 2014;2014:318–320. doi:10.1182/asheducation-2014.1.318
   PubMedGoogle Scholar
• Violi F, Lip GY, Cangemi R. Endotoxemia as a trigger of thrombosis in cirrhosis. Haematologica. 2016;101(4):e162–3. PMID: 27033239; PMCID: PMC5004387. doi:10.3324/haematol.2015.139972
   PubMed Web of Science ®Google Scholar
• Wang P, Tan F, Mu J, et al. Inhibitory effect of lactobacillus delbrueckii subsp. bulgaricus KSFY07 on Kappa-Carrageenan-induced thrombosis in mice and the regulation of oxidative damage. Cardiovasc Ther. 2022;15:4415876. doi:10.1155/2022/4415876
   Google Scholar
• Sandrin TR, Goldstein JE, Shoemaker S. MALDI TOF MS profiling of bacteria at the strain level: a review. Mass Spectrom Rev. 2013;32(3):188. doi:10.1002/mas.21359
   PubMed Web of Science ®Google Scholar
• Ji B, Nielsen J. From next-generation sequencing to systematic modeling of the gut microbiome. Front Genet. 2015;6:219. doi:10.3389/fgene.2015.00219
   PubMed Web of Science ®Google Scholar
• Friedrich-Rust M, Nierhoff J, Lupsor M, et al. Performance of ARFI imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepatol. 2012;19(2):e212–e219. doi:10.1111/j.1365-2893.2011.01537.x
   PubMed Web of Science ®Google Scholar
• Sirli R, Sporea I, Popescu A, Danila M. Ultrasound-based elastography for the diagnosis of portal hypertension in cirrhotics. World J Gastroenterol. 2015;21(41):11542. doi:10.3748/wjg.v21.i41.11542
   PubMed Web of Science ®Google Scholar
• Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG. The Liver and Portal Hypertension. Philadelphia: Saunders; 1964:50–64.
   Google Scholar
• Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–649. doi:10.1002/bjs.1800600817
   PubMed Web of Science ®Google Scholar
• Ennis J, Schultz G, Perera P, et al. Ultrasound for detection of ascites and for guidance of the paracentesis procedure: technique and review of the literature. Internat J Cl Med. 2014;5(20):1277–1293. doi:10.4236/ijcm.2014.520163
   Google Scholar
• Paquet KJ. Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices – a Prospective Controlled Randomized Trial. Endoscopy. 1982;14:4–5. doi:10.1055/s-2007-1021560
   PubMed Web of Science ®Google Scholar
• Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet. 1974;2(7877):394–397. doi:10.1016/S0140-6736(74)91770-X
   PubMed Web of Science ®Google Scholar
• Ferenci P. Hepatic encephalopathy. Gastroenterol Rep. 2017;5(2):138–147. doi:10.1093/gastro/gox013
   Google Scholar
• Larson K, Ho HH, Anumolu PL, Chen TM. Hematoxylin and eosin tissue stain in Mohs micrographic surgery; a review. Dermatol Surg. 2011;37(8):1089–1099. doi:10.1111/j.1524-4725.2011.02051.x
   PubMed Web of Science ®Google Scholar
• Basit SA, Stone CD, Gish R. Portal vein thrombosis. Clin Liver Dis. 2015;18:199–221. doi:10.1016/j.cld.2014.09.012
   Google Scholar
• Georgescu D, Georgescu LA, Muntean M, Lighezan D. Duplex abdominal examination in portal vein obstruction: how much can we rely on? Ultraschall der Medizin. 2016;37:S01. doi:10.1055/s-0036-1587774
   PubMedGoogle Scholar
• Margini C, Berzigotti A. Portal vein thrombosis: the role of imaging in the clinical setting. Dig Liv Dis. 2017;49(2):113–120. doi:10.1016/j.dld.2016.11.013
   Web of Science ®Google Scholar
• Mantaka A, Augoustaki A, Kouroumalis EA, Samonakis DN. Portal vein thrombosis in cirrhosis: diagnosis, natural history and therapeutical challenges. Ann Gastroenterol. 2018;31(3):315–329. doi:10.20524/aog.2018.0245
   PubMed Web of Science ®Google Scholar
• Huang X, Fan X, Zhang R, et al. Systemic inflammation and portal vein thrombosis in cirrhotic patient with gastroesophageal varices. Eur J Gastroenterol Hepatol. 2020;32(3):401–405. doi:10.1097/MEG.0000000000001526
   PubMed Web of Science ®Google Scholar
• Tsochartzis EA, Senzolo M, Germani G, Gatt A, Burroughs AK. Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther. 2010;31(3):366–374. doi:10.1111/j.1365-2036.2009.04182.x
   PubMed Web of Science ®Google Scholar
• Zocco MA, Stasio E, De Cristofaro R, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring and portal vein thrombosis development. J Hepatol. 2009;51:682–689. doi:10.1016/j.jhep.2009.03.013
   PubMed Web of Science ®Google Scholar
• Papatheodoridis GV, Chrysanthos N, Cholongitas E, et al. Thrombotic risk factors and liver histologic lesions in nonalcoholic fatty liver disease. J Hepatol. 2009;51(5):931–938. doi:10.1016/j.jhep.2009.06.023
   PubMed Web of Science ®Google Scholar
• Costache RS, Dragomirică AS, Dumitraș EA, et al. Portal vein thrombosis: a concise review. Exp Ther Med. 2021;22:759. doi:10.3892/etm.2021.10191
   PubMed Web of Science ®Google Scholar
• Kelly J, Rudd A, Lewis RR, et al. Plasma D-Dimers in the diagnosis of venous thromboembolism. Arch Intern Med. 2002;162(7):747–756. doi:10.1001/archinte.162.7.747
   PubMedGoogle Scholar
• Zhang DL, Hao JY, Ning Y. Value of D-dimers and protein S for diagnosis of portal vein thrombosis in patients with liver cirrhosis. J Int Med Res. 2013;41(3):664–672. doi:10.1177/0300060513483413
   PubMed Web of Science ®Google Scholar
• Dai J, Qi X, Li H, Guo X. Role of D-dimer in the development of portal vein thrombosis in liver cirrhosis: a metaanalysis. Saudi J Gastroenterol. 2015;21(3):165–174. doi:10.4103/1319-3767.157567
   PubMed Web of Science ®Google Scholar
• Zhu W, Wang Z, Tang WHW, Hazen SL. Gut microbe-generated Trimethylamine N-oxide from dietary choline is prothrombotic in subjects. Circulation. 2017;135(17):1671. doi:10.1161/CIRCULATIONAHA.116.025338
   PubMed Web of Science ®Google Scholar
• Nicoletti A, Ponziani FR, Biolato M, et al. Intestinal permeability in the pathogenesis of liver damage: from non-alcoholic fatty liver disease to liver transplantation. World J Gastroenterol. 2019;25(33):4814–4834. doi:10.3748/wjg.v25.i33.4814
   PubMed Web of Science ®Google Scholar
• Trebicka J, Bork P, Krag A, et al. Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure. Nat Rev Gastroenterol Hepatol. 2021;18(3):167–180. doi:10.1038/s41575-020-00376-3
   PubMed Web of Science ®Google Scholar
• Feng G, Yang X, Li Y, Wang X, Tan S, Chen F. LPS enhances platelets aggregation via TLR4, which is related to mitochondria damage caused by intracellular ROS, but not extracellular ROS. Cell Immunol. 2018;328:86–92. doi:10.1016/j.cellimm.2018.04.002
   PubMed Web of Science ®Google Scholar
• VGalgano L, Guidetti GF, Torti M, Canobbio I. The controversial role of LPS in platelet activation in vitro. Int J Mol Sci. 2022;23(18):10900. PMID: 36142813; PMCID: PMC9505944. doi:10.3390/ijms231810900
   PubMed Web of Science ®Google Scholar
• Martyanov AA, Maiorov AS, Filkova AA, et al. Effects of bacterial lipopolysaccharides on platelet function: inhibition of weak platelet activation. Sci Rep. 2020;2020(10):12296. doi:10.1038/s41598-020-69173-x
   Google Scholar
• Ana C, Antunes N, Pedro HL, et al. Tumor necrosis factor alpha has a crucial role in increased reactive oxygen species production in platelets of mice injected with lipopolysaccharide. Platelets. 2019;30:8, 1047–1052. doi:10.1080/09537104.2019.1588241
   PubMed Web of Science ®Google Scholar
• Trebicka J, Strassburg CP. Etiology and complications of portal vein thrombosis. Viszeralmedizin. 2014;30:375–380. doi:10.1159/000369987
   PubMedGoogle Scholar
• Faccia M, Santopaolo F, Gasbarrini A, Pompili M, Zocco MA, Ponziani FR. Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients. Intern Emerg Med. 2022;17(5):1327–1334. PMCID: PMC9352602. doi:10.1007/s11739-022-02928-8
   PubMed Web of Science ®Google Scholar
• Janssen HL, Wijhoud A, Haasma EB, et al. Extrahepatic portal vein thrombosis: etiology and determinants of survival. Gut. 2001;48:720–724. doi:10.1136/gut.49.5.720
   Google Scholar
• Muneer M, Abdelrahman H, El-Menyar A, Zarour A, Awad A, Al-Thani H. Acute cholecystitis complicated with portal vein thrombosis: a case report and literature review. Am J Case Rep. 2015;16:627–630. doi:10.12659/AJCR.894846
   PubMedGoogle Scholar
• Ozawa K, Shikino K. Pylephlebitis due to acute cholecystitis and cholangitis. BMJ. 2021;14:e244912. doi:10.1136/bcr-2021-244912
   Google Scholar
• Georgescu D, Ionita I, Lascu A, et al. Gallstone disease and bacterial metabolic performance of gut microbiota in middle-aged and older patients. Int J Gen Med. 2022;15:5513–5531. doi:10.2147/IJGM.S350104
   PubMed Web of Science ®Google Scholar
• Georgescu D, Caraba A, Ionita I, et al. Dyspepsia and gut microbiota in female patients with postcholecystectomy syndrome. Int J Women’s Health. 2022;14:41–56. doi:10.2147/IJWH.S342882
   PubMed Web of Science ®Google Scholar
• Chawla YK, Duseja A, Dhiman RK. Review article: the modern management of portal vein thrombosis. Aliment Pharmacol Ther. 2009;30(9):881–894. doi:10.1111/j.1365-2036.2009.04116.x
   PubMed Web of Science ®Google Scholar
• Harding DJ, Perera MTPR, Chen F, Olliff S, Tripathi D. Portal vein thrombosis in cirrhosis: controversies and latest developments. World J Gastroenterol. 2015;21(22):6769–6784. doi:10.3748/wjg.v21.i22.6769
   PubMed Web of Science ®Google Scholar
• Condat B, Pessione F, Hillaire S, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology. 2001;120:490–497. doi:10.1053/gast.2001.21209
   PubMed Web of Science ®Google Scholar
• Amitrano L, Guardascione MA, Menchise A, et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol. 2010;44:448–451. doi:10.1097/MCG.0b013e3181b3ab44
   PubMed Web of Science ®Google Scholar
• John BV, Konjeti R, Aggarwal A, et al. Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis. Ann Hepatol. 2013;12(6):952–958. doi:10.1016/S1665-2681(19)31301-8
   PubMed Web of Science ®Google Scholar
• Sharma AM, Zhu D, Henry Z. Portal vein thrombosis: when to treat and how? Vasc Med. 2016;21(1):61–69. doi:10.1177/1358863X15611224
   PubMed Web of Science ®Google Scholar
• Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol. 2007;7:34. doi:10.1186/1471-230X-7-34
   PubMed Web of Science ®Google Scholar
• Luca A, Caruso S, Milazzo M, et al. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology. 2012;265:124–132. doi:10.1148/radiol.12112236
   PubMed Web of Science ®Google Scholar
• Qi X, Han G, Fan D. Management of portal vein thrombosis in liver cirrhosis. Nat Rev Gastrenterol Hepatol. 2014;11:435–446. doi:10.1038/nrgastro.2014.36
   PubMed Web of Science ®Google Scholar
• Tzakos A, Kotnagianni VG, Tsoumani M, et al. Exploration of the antiplatelet activity profile of betulinic acid on human platelets. J Agric Food Chem. 2012;60(28):6977–6983. doi:10.1021/jf3006728
   PubMed Web of Science ®Google Scholar
• Nicolov M, Duse AO, Georgescu D, et al. Preliminary studies on betulinic acid crystals with organic solvents. Rev Chim. 2016;67(7):1411–1414.
   Web of Science ®Google Scholar
• Manzano-Robleda MC, Barranco-Fragoso B, Uribe M, Mendez-Sanchez N. Portal vein thrombosis: what is new? Ann Hepatol. 2015;14(1):20–27. doi:10.1016/S1665-2681(19)30797-5
   PubMed Web of Science ®Google Scholar
• Harki J, Plompen EP, van Noord D, et al. Gastrointestinal ischemia in patients with acute and chronic portal vein thrombosis. J Hepatol. 2014;60:S239–S240. doi:10.1016/S0168-8278(14)60672-3
   PubMed Web of Science ®Google Scholar
• Marcias I. Massive upper gastrointestinal bleeding due to splenoportal axis thrombosis in a patients with a tested JAK2 mutation; A case report and review literature. Int J Surg Case Rep. 2016;2(8):93–96. doi:10.1016/j.ijscr.2016.08.013
   Google Scholar
• Biecker E. Gastrointetinal bleeding in cirrhotic patients with portal hypertension. Int Schol Res Notices. 2013. doi:10.1155/2013/541836l
   Google Scholar
• Wallace A, Albadawi H, Hoang P, et al. Statins as a preventative therapy for venous thromboembolism. Cardiovasc Diagn Ther. 2017;7(Suppl 3):S207–S218. doi:10.21037/cdt.2017.09.12
   PubMedGoogle Scholar
• Bordbar M, de Mutsert R, Cevval M, et al. Differential effect of statin use on coagulation markers: an active comparative analysis in the NEO study. Thromb J. 2021;19(1):45. doi:10.1186/s12959-021-00299-2
   PubMed Web of Science ®Google Scholar
• Vieira- Silva S, Falony G, Belda E, et al. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature. 2020;581(7808):310–315. doi:10.1038/s41586-020-2269-x
   PubMedGoogle Scholar
• Dias AM, Cordeiro G, Estevinho MM, et al. Gut bacterial microbiome composition and statin intake - A systematic review. Pharmacol Res Perspect. 2020;8:e00601. doi:10.1002/prp2.601
   PubMed Web of Science ®Google Scholar
• Sha T, Zhang Y, Li C, et al. Association of metformin use with risk of venous thromboembolism in adults with type 2 diabetes: a general-population-based cohort study. Am J Epidemiol. 2022;191(5):856–866. PMID: 34999759. doi:10.1093/aje/kwab291
   PubMed Web of Science ®Google Scholar
• Alqahtan S, Mahzar M. Protective effect of metformin on venous thrombosis in diabetic patients: findings from a systematic review. J Endocrinol Met. 2022;12(6):161–167. doi:10.14740/jem848
   Web of Science ®Google Scholar
• Montandon SA, Jornayvaz FR. Effects of antidiabetic drugs on gut microbiota composition. Genes. 2017;8:250. doi:10.3390/genes810025
   PubMed Web of Science ®Google Scholar
• Rodriguez J, Hiel S, Delzenne NM. Metformin: old friend, new ways of action-implication of the gut microbiome? Curr Opin Clin Nutr Metab Care. 2018;21(4):294–301. PMID: 29634493. doi:10.1097/MCO.0000000000000468
   PubMed Web of Science ®Google Scholar
• Quarrie R, Stawicki SP. Portal vein thrombosis: what surgeons need to know. Int J Crit Illn Inj Sci. 2018;8(2):73–77. doi:10.4103/IJCIIS.IJCIIS_71_17
   PubMedGoogle Scholar
• Denninger MH, Chait Y, Casadeval N, et al. Cause of portal or hepatic vein thrombosis in adults: the role of multiple concurrent factors. Hepatology. 2000;3:587–591. doi:10.1002/hep.510310307
   Google Scholar
• Chen H, Turon F, Hernández‐Gea V, et al. Nontumoral portal vein thrombosis in patients awaiting liver transplantation. Liv Transpl. 2016;22(3):352–365. doi:10.1002/lt.24387
   PubMed Web of Science ®Google Scholar
• Nery F, Carneiro P, Correia S, et al. Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis: a prospective longitudinal study. Eur J Gastroenterol Hepatol. 2021;33(1S Suppl 1):e108–e113. PMID: 33208682. doi:10.1097/MEG.0000000000001982
   PubMed Web of Science ®Google Scholar
• Fede G, Privitera G, Tomaselli T, Spadaro L, Purrello F. Cardiovascular dysfunction in patients with liver cirrhosis. Ann Gastroenterol. 2015;28(1):31–40.
   PubMed Web of Science ®Google Scholar